Dickkopf-3 acts as a modulator of B cell fate and function

Journal of Immunology

Volumn 194, Issue 6, 2015, Pages 2624-2634

  Ludwig, Julia ^a   Federico, Giuseppina ^a   Prokosch, Sandra ^a   Kublbeck, G Gunter ^a   Schmitt, Sabine ^a   Klevenz, Alexandra ^a   Gröne, Hermann Josef ^a   Nitschke, Lars ^b   Arnold, Bernd ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; DICKKOPF 1 PROTEIN; INTERLEUKIN 10; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN G; UNCLASSIFIED DRUG; AUTOANTIBODY; CALCIUM; CYTOKINE; DKK3 PROTEIN, MOUSE; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; SIGLECG PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B1 CELL; B2 CELL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL FATE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HUMORAL IMMUNITY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DEFICIENCY; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; B-LYMPHOCYTES; CALCIUM; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, B-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84924588953     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402160     Document Type: Article

References (72)

1. Herzenberg, L. A., A. B. Kantor, and L. A. Herzenberg. 1992. Layered evolution in the immune system: a model for the ontogeny and development of multiple lymphocyte lineages. Ann. N. Y. Acad. Sci. 651: 1-9.
2. Godin, I. E., J. A. Garcia-Porrero, A. Coutinho, F. Dieterlen-Lièvre, and M. A. Marcos. 1993. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364: 67-70.
3. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
4. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, L. A. Herzenberg, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA 96: 2250-2255.
5. Yang, Y., J. W. Tung, E. E. Ghosn, L. A. Herzenberg, and L. A. Herzenberg. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 104: 4542-4546.
6. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
7. Montecino-Rodriguez, E., and K. Dorshkind. 2012. B-1 B cell development in the fetus and adult. Immunity 36: 13-21.
8. Dorshkind, K., and E. Montecino-Rodriguez. 2007. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat. Rev. Immunol. 7: 213-219.
9. Herzenberg, L. A. 2000. B-1 cells: the lineage question revisited. Immunol. Rev. 175: 9-22.
10. Gregoire, K. E., I. Goldschneider, R. W. Barton, and F. J. Bollum. 1979. Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse. J. Immunol. 123: 1347-1352.
11. Li, Y. S., K. Hayakawa, and R. R. Hardy. 1993. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178: 951-960.
12. Casola, S., K. L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, J. L. Kutok, M. C. Carroll, and K. Rajewsky. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5: 317-327.
13. Lam, K. P., and K. Rajewsky. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190: 471-477.
14. Arnold, L. W., C. A. Pennell, S. K. McCray, and S. H. Clarke. 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179: 1585-1595.
15. Chumley, M. J., J. M. Dal Porto, S. Kawaguchi, J. C. Cambier, D. Nemazee, and R. R. Hardy. 2000. A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro. J. Immunol. 164: 4586-4593.
16. Hardy, R. R., C. E. Carmack, Y. S. Li, and K. Hayakawa. 1994. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol. Rev. 137: 91-118.
17. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175: 70-79.
18. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7: 293-301.
19. Niehrs, C. 2006. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
20. Nakamura, R. E., and A. S. Hackam. 2010. Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 28: 232-242.
21. Krupnik, V. E., J. D. Sharp, C. Jiang, K. Robison, T. W. Chickering, L. Amaravadi, D. E. Brown, D. Guyot, G. Mays, K. Leiby, et al. 1999. Functional and structural diversity of the human Dickkopf gene family. Gene 238: 301-313.
22. Glinka, A., W. Wu, H. Delius, A. P. Monaghan, C. Blumenstock, and C. Niehrs. 1998. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391: 357-362.
23. Yue,W., Q. Sun, S. Dacic, R. J. Landreneau, J. M. Siegfried, J. Yu, and L. Zhang. 2008. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 29: 84-92.
24. Hoang, B. H., T. Kubo, J. H. Healey, R. Yang, S. S. Nathan, E. A. Kolb, B. Mazza, P. A. Meyers, and R. Gorlick. 2004. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res. 64: 2734-2739.
25. Caricasole, A., T. Ferraro, L. Iacovelli, E. Barletta, A. Caruso, D. Melchiorri, G. C. Terstappen, and F. Nicoletti. 2003. Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 3 LRP6 receptor complex and modulation by Dickkopf proteins. J. Biol. Chem. 278: 37024-37031.
26. Hermann, M., D. Pirkebner, A. Draxl, P. Berger, G. Untergasser, R. Margreiter, and P. Hengster. 2007. Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. Histochem. Cell Biol. 127: 513-521.
27. Zenzmaier, C., J. Marksteiner, A. Kiefer, P. Berger, and C. Humpel. 2009. Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients. J. Neurochem. 110: 653-661.
28. Papatriantafyllou, M., G. Moldenhauer, J. Ludwig, A. Tafuri, N. Garbi, G. Hollmann, G. Küblbeck, A. Klevenz, S. Schmitt, G. Pougialis, et al. 2012. Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance. Proc. Natl. Acad. Sci. USA 109: 1631-1636.
29. Barrantes, Idel. B., A. Montero-Pedrazuela, A. Guadaño-Ferraz, M. J. Obregon, R. Martinez de Mena, V. Gailus-Durner, H. Fuchs, T. J. Franz, S. Kalaydjiev, M. Klempt, et al. 2006. Generation and characterization of dickkopf3 mutant mice. Mol. Cell. Biol. 26: 2317-2326.
30. Constien, R., A. Forde, B. Liliensiek, H. J. Gröne, P. Nawroth, G. Hämmerling, and B. Arnold. 2001. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30: 36-44.
31. Hoffmann, A., S. Kerr, J. Jellusova, J. Zhang, F. Weisel, U. Wellmann, T. H. Winkler, B. Kneitz, P. R. Crocker, and L. Nitschke. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8: 695-704.
32. von Muenchow, L., C. Engdahl, K. Karjalainen, and A. G. Rolink. 2014. The selection of mature B cells is critically dependent on the expression level of the co-receptor CD19. Immunol. Lett. 160: 113-119.
33. Ramsey, L. B., A. L. Vegoe, A. T. Miller, M. P. Cooke, and M. A. Farrar. 2011. Tonic BCR signaling represses receptor editing via Raf-and calcium-dependent signaling pathways. Immunol. Lett. 135: 74-77.
34. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
35. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13: 655-692.
36. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409: 105-109.
37. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
38. Bucala, R. 1992. Polyclonal activation of B lymphocytes by lipopolysaccharide requires macrophage-derived interleukin-1. Immunology 77: 477-482.
39. Su, S. D., M. M. Ward, M. A. Apicella, and R. E. Ward. 1991. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J. Immunol. 146: 327-331.
40. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
41. Rolink, A., D. Haasner, F. Melchers, and J. Andersson. 1996. The surrogate light chain in mouse B-cell development. Int. Rev. Immunol. 13: 341-356.
42. Karasuyama, H., A. Rolink, and F. Melchers. 1996. Surrogate light chain in B cell development. Adv. Immunol. 63: 1-41.
43. Nemazee, D., V. Kouskoff, M. Hertz, J. Lang, D. Melamed, K. Pape, and M. Retter. 2000. B-cell-receptor-dependent positive and negative selection in immature B cells. Curr. Top. Microbiol. Immunol. 245: 57-71.
44. Kantor, A. B., A. M. Stall, S. Adams, L. A. Herzenberg, and L. A. Herzenberg. 1992. Adoptive transfer of murine B-cell lineages. Ann. N. Y. Acad. Sci. 651: 168-169.
45. Düber, S., M. Hafner, M. Krey, S. Lienenklaus, B. Roy, E. Hobeika, M. Reth, T. Buch, A. Waisman, K. Kretschmer, and S. Weiss. 2009. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114: 4960-4967.
46. Ghosn, E. E., R. Yamamoto, S. Hamanaka, Y. Yang, L. A. Herzenberg, H. Nakauchi, and L. A. Herzenberg. 2012. Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc Natl Acad Sci U S A. 109: 5394-5398.
47. Wardemann, H., T. Boehm, N. Dear, and R. Carsetti. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195: 771-780.
48. Nisitani, S., T. Tsubata, M. Murakami, and T. Honjo. 1995. Administration of interleukin-5 or-10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur. J. Immunol. 25: 3047-3052.
49. O'Garra, A., and M. Howard. 1992. IL-10 production by CD5 B cells. Ann. N. Y. Acad. Sci. 651: 182-199.
50. Ramachandra, S., R. A. Metcalf, T. Fredrickson, G. E. Marti, and E. Raveche. 1996. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. J. Clin. Invest. 98: 1788-1793.
51. Yen Chong, S., Y. C. Lin, J. Czarneski, M. Zhang, F. Coffman, F. Kashanchi, and E. Raveche. 2001. Cell cycle effects of IL-10 on malignant B-1 cells. Genes Immun. 2: 239-247.
52. Bendelac, A., M. Bonneville, and J. F. Kearney. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1: 177-186.
53. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, C. A. Lowell, and T. F. Tedder. 2001. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice. J. Immunol. 167: 2469-2478.
54. Lin, H., and R. Grosschedl. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267.
55. Vilagos, B., M. Hoffmann, A. Souabni, Q. Sun, B. Werner, J. Medvedovic, I. Bilic, M. Minnich, E. Axelsson, M. Jaritz, and M. Busslinger. 2012. Essential role of EBF1 in the generation and function of distinct mature B cell types. J. Exp. Med. 209: 775-792.
56. Kano, J., T. Ishiyama, T. Iijima, Y. Morishita, S. Murata, K. Hisakura, N. Ohkohchi, and M. Noguchi. 2008. Differentially expressed genes in a porcine adult hepatic stem-like cell line and their expression in developing and regenerating liver. Lab. Invest. 88: 132-143.
57. Untergasser, G., A. Martowicz, M. Hermann, S. Töchterle, and D. Meyer. 2011. Distinct expression patterns of dickkopf genes during late embryonic development of Danio rerio. Gene Expr. Patterns 11: 491-500.
58. Fu, C. Y., Y. F. Su, M. H. Lee, G. D. Chang, and H. J. Tsai. 2012. Zebrafish Dkk3a protein regulates the activity of myf5 promoter through interaction with membrane receptor integrin a6b. J. Biol. Chem. 287: 40031-40042.
59. Kataoka, K., M. Sakaguchi, K. P. Li, C. Taketa, K. Yamamoto, G. Du, H. Funahashi, H. Murata, and N. H. Huh. 2010. Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extraembryonic tissues. Int. J. Mol. Med. 26: 853-859.
60. Lee, E. J., M. Jo, S. B. Rho, K. Park, Y. N. Yoo, J. Park, M. Chae, W. Zhang, and J. H. Lee. 2009. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int. J. Cancer 124: 287-297.
61. Reya, T., R. Okamura, and R. Grosschedl. 1999. Control of lymphocyte differentiation by the LEF-1/TCF family of transcription factors. Cold Spring Harb. Symp. Quant. Biol. 64: 133-140.
62. Ranheim, E. A., H. C. Kwan, T. Reya, Y. K. Wang, I. L. Weissman, and U. Francke. 2005. Frizzled 9 knock-out mice have abnormal B-cell development. Blood 105: 2487-2494.
63. Baba, Y., K. P. Garrett, and P. W. Kincade. 2005. Constitutively active betacatenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Immunity 23: 599-609.
64. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
65. Grönwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3: 66.
66. Dauphinée, M., Z. Tovar, and N. Talal. 1988. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum. 31: 642-647.
67. Youinou, P., L.Mackenzie, P. Katsikis, G. Merdrignac, D. A. Isenberg, N. Tuaillon, A. Lamour, P. Le Goff, J. Jouquan, A. Drogou, et al. 1990. The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arthritis Rheum. 33: 339-348.
68. Murakami, M., and T. Honjo. 1995. B-1 cells and autoimmunity. Ann. N. Y. Acad. Sci. 764: 402-409.
69. Xu, Z., E. J. Butfiloski, E. S. Sobel, and L. Morel. 2004. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J. Immunol. 173: 6050-6058.
70. Kalampokis, I., A. Yoshizaki, and T. F. Tedder. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl. 1): S1.
71. Binder, C. J., S. Hörkkö, A. Dewan, M. K. Chang, E. P. Kieu, C. S. Goodyear, P. X. Shaw,W. Palinski, J. L.Witztum, and G. J. Silverman. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9: 736-743.
72. Rose, N., and M. Afanasyeva. 2003. Autoimmunity: busting the atherosclerotic plaque. Nat. Med. 9: 641-642.